Jeannette Lechner-Scott

19PUBLICATIONS
120CO-AUTHORS
Semi- and unsupervised learningMemory and attentionEnvironmental epidemiologyGene and molecular therapySensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 01, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

|Mar 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study.

Bruno Brochet, Dawn Langdon, Eva Kubala Havrdova

|Oct 10, 2025
Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset.

Steve Simpson-Yap, Ellen Morwitch, Samuel A Tanner

|Jul 22, 2025
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

Avani Yeola, Samuel Houston, Anupriya Aggarwal

|Feb 26, 2025
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis.

Yi Chao Foong, Daniel Merlo, Melissa Gresle

|Jan 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.

Vivien Li, Fiona C McKay, David C Tscharke

Pageof 4

Frequent Collaborators

12 joint publications

Tomas Kalincik

10 joint publications

Anneke van der Walt

8 joint publications

Francesco Patti

7 joint publications

Bruce V Taylor